Catherine Novack
Stock Analyst at Jones Trading
(2.34)
# 2,697
Out of 5,091 analysts
22
Total ratings
27.78%
Success rate
8.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Novack
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Downgrades: Hold | n/a | $7.54 | - | 2 | Nov 14, 2025 | |
| AARD Aardvark Therapeutics | Initiates: Buy | $33 | $13.82 | +138.78% | 1 | Oct 1, 2025 | |
| DYN Dyne Therapeutics | Initiates: Buy | $30 | $22.20 | +35.14% | 1 | Jun 26, 2025 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $40 → $29 | $28.56 | +1.54% | 2 | Jun 25, 2025 | |
| FEMY Femasys | Maintains: Buy | $10 → $6 | $0.82 | +633.94% | 2 | May 13, 2025 | |
| RLYB Rallybio | Downgrades: Hold | n/a | $0.68 | - | 1 | Apr 15, 2025 | |
| PVLA Palvella Therapeutics | Initiates: Buy | $45 | $100.91 | -55.41% | 1 | Mar 25, 2025 | |
| PRQR ProQR Therapeutics | Initiates: Buy | $11 | $2.12 | +418.87% | 1 | Feb 12, 2025 | |
| EQ Equillium | Downgrades: Hold | n/a | $0.87 | - | 1 | Nov 1, 2024 | |
| WVE Wave Life Sciences | Maintains: Buy | $12 → $16 | $18.52 | -13.61% | 2 | Sep 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $3.82 | +266.49% | 1 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $13 | $1.84 | +606.52% | 2 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $10.17 | -1.67% | 1 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $4.41 | +398.87% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.28 | - | 2 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $160 | $0.80 | +19,885.01% | 1 | Jul 21, 2023 |
Korro Bio
Nov 14, 2025
Downgrades: Hold
Price Target: n/a
Current: $7.54
Upside: -
Aardvark Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $33
Current: $13.82
Upside: +138.78%
Dyne Therapeutics
Jun 26, 2025
Initiates: Buy
Price Target: $30
Current: $22.20
Upside: +35.14%
Capricor Therapeutics
Jun 25, 2025
Maintains: Buy
Price Target: $40 → $29
Current: $28.56
Upside: +1.54%
Femasys
May 13, 2025
Maintains: Buy
Price Target: $10 → $6
Current: $0.82
Upside: +633.94%
Rallybio
Apr 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.68
Upside: -
Palvella Therapeutics
Mar 25, 2025
Initiates: Buy
Price Target: $45
Current: $100.91
Upside: -55.41%
ProQR Therapeutics
Feb 12, 2025
Initiates: Buy
Price Target: $11
Current: $2.12
Upside: +418.87%
Equillium
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.87
Upside: -
Wave Life Sciences
Sep 25, 2024
Maintains: Buy
Price Target: $12 → $16
Current: $18.52
Upside: -13.61%
Sep 12, 2024
Initiates: Buy
Price Target: $14
Current: $3.82
Upside: +266.49%
Aug 16, 2024
Maintains: Buy
Price Target: $5 → $13
Current: $1.84
Upside: +606.52%
Apr 18, 2024
Initiates: Buy
Price Target: $10
Current: $10.17
Upside: -1.67%
Feb 16, 2024
Initiates: Buy
Price Target: $22
Current: $4.41
Upside: +398.87%
Oct 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $6.28
Upside: -
Jul 21, 2023
Initiates: Buy
Price Target: $160
Current: $0.80
Upside: +19,885.01%